Companies

Takeda

Mentioned in 2 analyzed podcast episodes across 2 shows

Episode Mentions

Pharma and BioTech Daily

Pharma and BioTech Daily · Jul 20, 2026

Jasper Merges with Kira for $292M | Pharma and Biotech Daily

Zasacitinib demonstrated 75% scalp psoriasis clearance in Phase 3 trials as TYK2 inhibitor

Jasper-Kira Pharmaceuticals MergerAutoimmune Therapeutics DevelopmentTYK2 Inhibitors for Psoriasis
View Analysis
CNBC's "Fast Money"

CNBC's "Fast Money" · May 5, 2026

Intel & Memory Stocks Surge… And Protagonist CEO On Drug Approval 5/5/26

Licensing partner for Protagonist's Rasvertide drug for rare blood disease; expected FDA approval Q3 2026

AI Infrastructure Investment and Chip CompetitionCloud Computing Backlog Concentration RiskSemiconductor Market Diversification from NVIDIA
View Analysis